MX9701390A - Formulaciones farmaceuticas mejoradas que contienen ibuprofeno y codeina. - Google Patents
Formulaciones farmaceuticas mejoradas que contienen ibuprofeno y codeina.Info
- Publication number
- MX9701390A MX9701390A MX9701390A MX9701390A MX9701390A MX 9701390 A MX9701390 A MX 9701390A MX 9701390 A MX9701390 A MX 9701390A MX 9701390 A MX9701390 A MX 9701390A MX 9701390 A MX9701390 A MX 9701390A
- Authority
- MX
- Mexico
- Prior art keywords
- codeine
- pharmaceutical formulations
- formulations containing
- improved pharmaceutical
- containing ibuprofen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describen formulaciones de ibuprofeno y codeina ( o una sal farmacéuticamente aceptable de cualquiera de ellos) que incluyen un vehículo que comprende un agente desintegrador, un diluyente, y un lubricante substancialmente libre de un lubricante de ácido esteárico y iones de estearato y seleccionado de aceites vegetales hidrogenados. Las formulaciones preferidas son tabletas directamente comprimidas, las cuales son utiles para el tratamiento de dolor e inflamacion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9417041A GB9417041D0 (en) | 1994-08-23 | 1994-08-23 | Improved formulations |
GB9419921A GB9419921D0 (en) | 1994-10-04 | 1994-10-04 | Improved formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9701390A true MX9701390A (es) | 1998-06-30 |
Family
ID=26305507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9701390A MX9701390A (es) | 1994-08-23 | 1997-02-24 | Formulaciones farmaceuticas mejoradas que contienen ibuprofeno y codeina. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0777477B1 (es) |
JP (1) | JP3874793B2 (es) |
KR (1) | KR100397082B1 (es) |
CN (1) | CN1083265C (es) |
AT (1) | ATE227574T1 (es) |
AU (1) | AU699224B2 (es) |
BG (1) | BG63329B1 (es) |
BR (1) | BR9508760A (es) |
CA (1) | CA2156768A1 (es) |
CZ (1) | CZ287558B6 (es) |
DE (1) | DE69528838T2 (es) |
DK (1) | DK0777477T3 (es) |
ES (1) | ES2187566T3 (es) |
HU (1) | HU227759B1 (es) |
MX (1) | MX9701390A (es) |
NO (1) | NO322200B1 (es) |
NZ (1) | NZ291223A (es) |
PL (1) | PL181215B1 (es) |
PT (1) | PT777477E (es) |
RU (1) | RU2140782C1 (es) |
SK (1) | SK282183B6 (es) |
TW (1) | TW493984B (es) |
UA (1) | UA42781C2 (es) |
WO (1) | WO1996005834A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6608073B1 (en) | 1998-10-14 | 2003-08-19 | New Millennium Pharmaceutical Research, Inc. | Intranasal codeine for the rapid suppression of cough and rapid relief of pain |
US6368618B1 (en) | 1999-07-01 | 2002-04-09 | The University Of Georgia Research Foundation, Inc. | Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
JP2001253826A (ja) * | 2000-03-09 | 2001-09-18 | Maruzen Pharmaceut Co Ltd | 内服用剤 |
US7183410B2 (en) | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US20040253311A1 (en) * | 2002-12-18 | 2004-12-16 | Roger Berlin | Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines |
PL1912650T3 (pl) | 2005-08-03 | 2018-01-31 | Sprout Pharmaceuticals Inc | Zastosowanie flibanseryny w leczeniu otyłości |
WO2007048803A1 (en) | 2005-10-29 | 2007-05-03 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
ZA200803566B (en) * | 2005-12-12 | 2009-10-28 | Adcock Ingram Ltd | Pharmaceutical compositions |
US20090312242A1 (en) | 2006-06-30 | 2009-12-17 | Ramiro Castro | Flibanserin for the treatment of urinary incontinence and related diseases |
US8034801B2 (en) | 2006-07-12 | 2011-10-11 | Aska Pharmaceutical Co., Ltd. | Analgesic agent |
AR062320A1 (es) | 2006-08-14 | 2008-10-29 | Boehringer Ingelheim Int | Formulaciones de flibanserina y metodo para fabricarlas |
CN104721168A (zh) | 2006-08-25 | 2015-06-24 | 贝林格尔·英格海姆国际有限公司 | 控制释放系统及其制造方法 |
WO2008044331A1 (fr) * | 2006-10-05 | 2008-04-17 | Kowa Company, Ltd. | Préparation solide comprenant de l'ibuprofène et de l'acide tranexamique |
UY31335A1 (es) | 2007-09-12 | 2009-04-30 | Tratamiento de sintomas vasomotores | |
ES2400006T3 (es) | 2008-04-23 | 2013-04-04 | Farmasierra Manufacturing, S.L. | Formulación farmacéutica mejorada a base de ibuprofeno y codeína |
ES2365961B1 (es) | 2010-03-30 | 2013-01-24 | Farmasierra Manufacturing S.L. | Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada. |
KR101317809B1 (ko) * | 2011-06-07 | 2013-10-16 | 한미약품 주식회사 | 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물 |
KR20140096571A (ko) | 2013-01-28 | 2014-08-06 | 한미약품 주식회사 | 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법 |
PT3185855T (pt) | 2014-08-28 | 2022-12-13 | Sanofi Aventis Deutschland | Comprimido revestido por película para o tratamento da dor aguda |
CN105395508B (zh) * | 2015-12-14 | 2018-06-29 | 西南药业股份有限公司 | 一种洛芬待因复方制剂及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571400A (en) * | 1984-12-18 | 1986-02-18 | Belleview Pharmaceutical, Inc. | Dihydrocodeine/ibuprofen pharmaceutical compositions and method |
GB8905815D0 (en) * | 1989-03-14 | 1989-04-26 | Beecham Group Plc | Medicament |
GB9121204D0 (en) * | 1991-10-04 | 1991-11-20 | Euro Celtique Sa | Medicament |
-
1995
- 1995-08-16 RU RU97104235A patent/RU2140782C1/ru active
- 1995-08-16 HU HU9701774A patent/HU227759B1/hu unknown
- 1995-08-16 JP JP50785696A patent/JP3874793B2/ja not_active Expired - Fee Related
- 1995-08-16 PT PT95928574T patent/PT777477E/pt unknown
- 1995-08-16 ES ES95928574T patent/ES2187566T3/es not_active Expired - Lifetime
- 1995-08-16 EP EP95928574A patent/EP0777477B1/en not_active Expired - Lifetime
- 1995-08-16 NZ NZ291223A patent/NZ291223A/xx not_active IP Right Cessation
- 1995-08-16 WO PCT/GB1995/001947 patent/WO1996005834A1/en active IP Right Grant
- 1995-08-16 DE DE69528838T patent/DE69528838T2/de not_active Expired - Lifetime
- 1995-08-16 BR BR9508760A patent/BR9508760A/pt not_active IP Right Cessation
- 1995-08-16 AT AT95928574T patent/ATE227574T1/de active
- 1995-08-16 CN CN95195426A patent/CN1083265C/zh not_active Expired - Fee Related
- 1995-08-16 CZ CZ1997546A patent/CZ287558B6/cs not_active IP Right Cessation
- 1995-08-16 SK SK236-97A patent/SK282183B6/sk not_active IP Right Cessation
- 1995-08-16 DK DK95928574T patent/DK0777477T3/da active
- 1995-08-16 AU AU32289/95A patent/AU699224B2/en not_active Ceased
- 1995-08-16 UA UA97020807A patent/UA42781C2/uk unknown
- 1995-08-16 KR KR1019970701128A patent/KR100397082B1/ko not_active IP Right Cessation
- 1995-08-16 PL PL95318807A patent/PL181215B1/pl not_active IP Right Cessation
- 1995-08-22 TW TW084108754A patent/TW493984B/zh not_active IP Right Cessation
- 1995-08-23 CA CA002156768A patent/CA2156768A1/en not_active Abandoned
-
1997
- 1997-02-20 NO NO19970782A patent/NO322200B1/no not_active IP Right Cessation
- 1997-02-21 BG BG101252A patent/BG63329B1/bg unknown
- 1997-02-24 MX MX9701390A patent/MX9701390A/es not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT77385A (hu) | Ibuprofent és kodeint tartalmazó, tökéletesített gyógyászati készítmények | |
MY112915A (en) | Multiple unit tableted dosage form 1 | |
IL127244A0 (en) | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | |
PL337126A1 (en) | Novel compounds | |
AU3632497A (en) | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
BG104727A (en) | Pharmaceutical composition of topiramate | |
GEP20002013B (en) | Therapeutical Means | |
HU9600572D0 (en) | Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form | |
PL320822A1 (en) | Sulphonamidic compounds as therapeutic agents for treatment of central nervous system, method of obtaining novel sulphonamidic compounds and drugs containing such compounds | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
EP0793660A4 (en) | 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE | |
MY113908A (en) | Rapidly disintegrating formulation comprising tramadol or a tramadol salt | |
IL101358A0 (en) | Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
EP1169058A4 (en) | INSULIN-LIKE GROWTH FACTOR AND BINDING PROTEIN PROTEIN 4 | |
IL110011A0 (en) | Pharmaceutical compositions for the treatment of schizophrenia | |
MY118175A (en) | Crystalline pharmaceutical product | |
UA42749C2 (uk) | N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування | |
WO2001021178A3 (en) | Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs | |
JO1880B1 (en) | Format 1 for multi-unit calibration discs | |
MX9707719A (es) | Preparado en combinacion que contiene tramadol y un antagonista del canal de calcio. | |
WO2003014328A3 (en) | Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease | |
PL299147A1 (en) | Pharmaceutical agent for treating central nerve system disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |